New Insight Wealth Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$344K Sell
374
-10
-3% -$10.1K 0.12% 86
2025
Q4
$412K Buy
384
+11
+3% +$10.5K 0.15% 81
2025
Q3
$285K Sell
373
-21
-5% -$15.6K 0.11% 94
2025
Q2
$307K Buy
394
+13
+3% +$10.1K 0.13% 86
2025
Q1
$315K Buy
+381
New +$317K 0.14% 77

Other funds holding LLY

New Insight Wealth Advisors's LLY Position: Q1 2026 in Review

New Insight Wealth Advisors reduced its Eli Lilly (LLY) stake by 2.6% in Q1 2026, selling an estimated $10.1K and leaving 374 shares worth $344K. The position accounts for 0.12% of the portfolio, ranked #86.

New Insight Wealth Advisors first reported a position in LLY in Q1 2025 and has held it in 5 quarters since. The position peaked at $412K in Q4 2025. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • New Insight Wealth Advisors held 374 shares of Eli Lilly worth $344K as of Q1 2026.
  • New Insight Wealth Advisors sold 10 Eli Lilly shares in Q1 2026, an estimated $10.1K.
  • Eli Lilly made up 0.12% of New Insight Wealth Advisors's portfolio in Q1 2026, its #86 holding.
  • New Insight Wealth Advisors first reported a position in Eli Lilly in Q1 2025 and has held it in 5 quarters since.
  • New Insight Wealth Advisors's Eli Lilly position peaked at $412K in Q4 2025.
  • 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on New Insight Wealth Advisors's 13F filing for Q1 2026, filed 8 May 2026.